Brain/Neuro Cancer: Newly Diagnosed Clinical Trials

Showing 1-5 of 5 items
1.
2.
  • Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
  • RATIONALE: Giving chemotherapy before an autologous stem cell transplant stops the growth of cancer cells by stopping them from dividing or killing them. After treatment, stem cells are collected from the patient's blood and stored. More chemotherapy or radiation therapy is given to prepare the bone marrow for the stem cell transplant. The stem cells are then returned to the patient to replace the blood-forming cells that were destroyed by the chemotherapy. PURPOSE: This randomized phase II trial studies how well combination chemotherapy given together with autologous stem cell transplant works compared to combination chemotherapy alone in treating patients with central nervous system B-cell lymphoma.
  • Diagnoses: Brain/Neuro Cancer: Newly Diagnosed
  • Status: Recruiting
3.
4.
5.
Showing 1-5 of 5 items
  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms